List of Tables
Table 1. Global Gene Editing Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Gene Editing Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Gene Editing Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Gene Editing Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Gene Editing Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Gene Editing Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Gene Editing Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Gene Editing Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Gene Editing Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gene Editing Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gene Editing Drug, Product Type & Application
Table 12. Global Key Manufacturers of Gene Editing Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gene Editing Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gene Editing Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Gene Editing Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Gene Editing Drug Sales Market Share by Region (2019-2024)
Table 19. Global Gene Editing Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Gene Editing Drug Sales Market Share by Region (2025-2030)
Table 21. Global Gene Editing Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Gene Editing Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Gene Editing Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Gene Editing Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Gene Editing Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Gene Editing Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Gene Editing Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Gene Editing Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Gene Editing Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Gene Editing Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Gene Editing Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Gene Editing Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Gene Editing Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Gene Editing Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Gene Editing Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Gene Editing Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Gene Editing Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Gene Editing Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Gene Editing Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gene Editing Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Gene Editing Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Gene Editing Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Gene Editing Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Gene Editing Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Gene Editing Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Gene Editing Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Gene Editing Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Gene Editing Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Gene Editing Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Gene Editing Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Gene Editing Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Gene Editing Drug Sales Market Share by Type (2019-2024)
Table 53. Global Gene Editing Drug Sales Market Share by Type (2025-2030)
Table 54. Global Gene Editing Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Gene Editing Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Gene Editing Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Gene Editing Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Gene Editing Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global Gene Editing Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global Gene Editing Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Gene Editing Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Gene Editing Drug Sales Market Share by Application (2019-2024)
Table 63. Global Gene Editing Drug Sales Market Share by Application (2025-2030)
Table 64. Global Gene Editing Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Gene Editing Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Gene Editing Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Gene Editing Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Gene Editing Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global Gene Editing Drug Price (US$/Unit) by Application (2025-2030)
Table 70. CRISPR Therapeutics Corporation Information
Table 71. CRISPR Therapeutics Description and Business Overview
Table 72. CRISPR Therapeutics Gene Editing Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. CRISPR Therapeutics Gene Editing Drug Product
Table 74. CRISPR Therapeutics Recent Developments/Updates
Table 75. Editas Medicine Corporation Information
Table 76. Editas Medicine Description and Business Overview
Table 77. Editas Medicine Gene Editing Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Editas Medicine Gene Editing Drug Product
Table 79. Editas Medicine Recent Developments/Updates
Table 80. Intellia Therapeutics Corporation Information
Table 81. Intellia Therapeutics Description and Business Overview
Table 82. Intellia Therapeutics Gene Editing Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Intellia Therapeutics Gene Editing Drug Product
Table 84. Intellia Therapeutics Recent Developments/Updates
Table 85. Sangamo Therapeutics Corporation Information
Table 86. Sangamo Therapeutics Description and Business Overview
Table 87. Sangamo Therapeutics Gene Editing Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Sangamo Therapeutics Gene Editing Drug Product
Table 89. Sangamo Therapeutics Recent Developments/Updates
Table 90. Bluebird Bio Corporation Information
Table 91. Bluebird Bio Description and Business Overview
Table 92. Bluebird Bio Gene Editing Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Bluebird Bio Gene Editing Drug Product
Table 94. Bluebird Bio Recent Developments/Updates
Table 95. Beam Therapeutics Corporation Information
Table 96. Beam Therapeutics Description and Business Overview
Table 97. Beam Therapeutics Gene Editing Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Beam Therapeutics Gene Editing Drug Product
Table 99. Beam Therapeutics Recent Developments/Updates
Table 100. Yaotang Biotechnology Corporation Information
Table 101. Yaotang Biotechnology Description and Business Overview
Table 102. Yaotang Biotechnology Gene Editing Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Yaotang Biotechnology Gene Editing Drug Product
Table 104. Yaotang Biotechnology Recent Developments/Updates
Table 105. ICamuno Biotherapeutics Corporation Information
Table 106. ICamuno Biotherapeutics Description and Business Overview
Table 107. ICamuno Biotherapeutics Gene Editing Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. ICamuno Biotherapeutics Gene Editing Drug Product
Table 109. ICamuno Biotherapeutics Recent Developments/Updates
Table 110. Reforgene Medicine Corporation Information
Table 111. Reforgene Medicine Description and Business Overview
Table 112. Reforgene Medicine Gene Editing Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Reforgene Medicine Gene Editing Drug Product
Table 114. Reforgene Medicine Recent Developments/Updates
Table 115. Star Eyed Creature Corporation Information
Table 116. Star Eyed Creature Description and Business Overview
Table 117. Star Eyed Creature Gene Editing Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Star Eyed Creature Gene Editing Drug Product
Table 119. Star Eyed Creature Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Gene Editing Drug Distributors List
Table 123. Gene Editing Drug Customers List
Table 124. Gene Editing Drug Market Trends
Table 125. Gene Editing Drug Market Drivers
Table 126. Gene Editing Drug Market Challenges
Table 127. Gene Editing Drug Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gene Editing Drug
Figure 2. Global Gene Editing Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Gene Editing Drug Market Share by Type in 2023 & 2030
Figure 4. CRISPR-Cas9 Gene Editing Drugs Product Picture
Figure 5. Zinc Finger Nuclease Gene Editing Drugs Product Picture
Figure 6. Others Product Picture
Figure 7. Global Gene Editing Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Gene Editing Drug Market Share by Application in 2023 & 2030
Figure 9. General Hospital
Figure 10. Specialty Hospital
Figure 11. Global Gene Editing Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Gene Editing Drug Market Size (2019-2030) & (US$ Million)
Figure 13. Global Gene Editing Drug Sales (2019-2030) & (K Units)
Figure 14. Global Gene Editing Drug Average Price (US$/Unit) & (2019-2030)
Figure 15. Gene Editing Drug Report Years Considered
Figure 16. Gene Editing Drug Sales Share by Manufacturers in 2023
Figure 17. Global Gene Editing Drug Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Gene Editing Drug Players: Market Share by Revenue in 2023
Figure 19. Gene Editing Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Gene Editing Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Gene Editing Drug Sales Market Share by Country (2019-2030)
Figure 22. North America Gene Editing Drug Revenue Market Share by Country (2019-2030)
Figure 23. United States Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Gene Editing Drug Sales Market Share by Country (2019-2030)
Figure 26. Europe Gene Editing Drug Revenue Market Share by Country (2019-2030)
Figure 27. Germany Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Gene Editing Drug Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Gene Editing Drug Revenue Market Share by Region (2019-2030)
Figure 34. China Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Gene Editing Drug Sales Market Share by Country (2019-2030)
Figure 42. Latin America Gene Editing Drug Revenue Market Share by Country (2019-2030)
Figure 43. Mexico Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Gene Editing Drug Sales Market Share by Country (2019-2030)
Figure 47. Middle East & Africa Gene Editing Drug Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Gene Editing Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Gene Editing Drug by Type (2019-2030)
Figure 52. Global Revenue Market Share of Gene Editing Drug by Type (2019-2030)
Figure 53. Global Gene Editing Drug Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Gene Editing Drug by Application (2019-2030)
Figure 55. Global Revenue Market Share of Gene Editing Drug by Application (2019-2030)
Figure 56. Global Gene Editing Drug Price (US$/Unit) by Application (2019-2030)
Figure 57. Gene Editing Drug Value Chain
Figure 58. Gene Editing Drug Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
